-
Xiaoxia Shi, Yixin Du, Shujing Li, Huijian Wu*, The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells, International Journal of Molecular Science, 2022, 23(7). \
-
Giulia Bortolussi#, Xiaoxia Shi#, Lysbeth Bloemendaal, Bhaswati Banerjee, Dirk Waart, Gabriele Baj, Weiyu Chen, Ronald Oude Elferink, Ulrich Beuers, Coen Paulusma, Roland Stocker, Andrés Muro, Piter Bosma*, Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1-/- Mice: Impact on Redox Status and Metabolism, Antioxidants, 2021, 10.
-
Xiaoxia Shi, Sem Aronson, Lysbeth Bloemendaal, Suzanne Duijst, Robert Bakker, Dirk Waart, Giulia Bortolussi, Fanny Collaud, Ronald Oude Elferink, Andrés Muro, Federico Mingozzi, Giuseppe Ronzitti, Piter Bosma*, Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients, Molecular Therapy-Methods & Clinical Development, 2021, 20: 287-297.
-
Xiaoxia Shi*, Giulia Bortolussi, Lysbeth Ten Bloemendaal, Suzanne Duijst, Andrés F Muro, Piter J Bosma, Low efficacy of recombinant SV40 in Ugt1a1-/- mice with severe inherited hyperbilirubinemia., PLoS One, 2021, 16.
-
Xiaoxia Shi*, Sem Aronson, AS Khan, Piter J Bosma. A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report. BMC Pediatrics. 2019 May, 173.
-
Xiaoxia Shi, Matthew Ryan Ykema, Jaco Hazenoot, Lysbeth Bloemendaal, Irene Mancini, Machteld Odijk, Peter Haan, Piter Bosma*, Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40., Molecular Therapy-Methods & Clinical Development, 2018, 9: 225-233.
-
Yanan Li#, Shujing Li#, Xiaoxia Shi, Zhiqiang Xin, Yuxi Yang, Binggong Zhao, Yulin Li, linlin Lv, Ping Ren, and Huijian Wu*. KLF12 promotes the proliferation of breast cancer cells by reducing the transcription of p21 in a p53-dependent and p53-independent manner. Cell Death and Disease. 2023 May 8,14(5):313.
-
Bowen Li#, Shujing Li#, Xiaoxia Shi, Yini Zhang, Zhiqiang Xin, Yuxi Yang, Binggong Zhao, Ping Ren*, Huijian Wu*. MZF1 (Myeloid Zinc Finger 1) activates transcriptional activity of p53 and suppresses breast cancer cell proliferation via acetyltransferase PCAF (P300/CBP associated factor). Genes & Diseases. 2022, ISSN 2352-3042.
-
Kangkai Xia#, Shujing Li#, Yuxi Yang, Xiaoxia Shi, Binggong Zhao, Linlin Lv, Zhiqiang Xin, Jie Kang, Ping Ren* and Huijian Wu*. Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer. Cell Death and Disease. 2023 Apr 6,14(4):250.
-
Binggong Zhao#, Wei Huo#, Xiaomin Yu, Xiaoxia Shi, Linlin Lv, Yuxi Yang, Jie Kang, Shujing Li, Huijian Wu*. USP13 promotes breast cancer metastasis through FBXL14 induced Twist1 ubiquitination. Cellular Oncology. 2023 Feb 3.
-
Sem Aronson, Robert Bakker, Xiaoxia Shi, Suzan Duijst, Lysbeth Bloemendaal, DR Waart, J Verheij, G Ronzitti, Ronald Oude Elferink, Ulrich Beuers, Coen Paulusma, Piter Bosma*. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice. Journal of Hepatology. 2019 Jul,71(1):153-162.
-
Ilan Koppen, Mana Vriesman, Miguel Saps, Shaman Rajindrajith, Xiaoxia Shi, Faridi Etten-Jamaludin, Carlo Lorenzo, Marc Benninga, Merit Tabbers. Prevalence of Functional Defecation Disorders in Children: A Systematic Review and Meta-Analysis. Journal of Pediatrics. 2018 Jul,198:121-130.
-
Sem Aronson, Robert Bakker, Sascha Moenis, Remco Dijk, Giulia Bortolussi, Fanny Collaud, Xiaoxia Shi, Suzanne Duijst, Lysbeth Bloemendaal, Giuseppe Ronzitti, Andrés Muro, Federico Mingozzi, Ulrich Beuers, Piter Bosma. A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene. Molecular Therapy-Methods & Clinical Development, 2020 Jun 3,18:250-258.
-
Xiaoxia Shi*, Giulia Bortolussi*, Fanny Collaud*, Pierre-Romain Lebrun, Lysbeth Bloemendaal, Nicolas Guerchet, Dirk Rudi de Waart, Pauline Sellier, Suzanne Duijst, Philippe Veron, Federico Mingozzi, Takashi Kei Kishimoto, Giuseppe Ronzitti#, Piter Bosma#, Andrés F. Muro#, Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type I. Molecular Therapy Methods & Clinical Development, 2024.
当前位置: